Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

NCT06850506 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06850506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06850506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2024
Completion date
September 1, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, osteosarcoma, sarcoma, sarcoma, bone